PDS Biotechnology Corp reports results for the quarter ended in December - Earnings Summary

PDS Biotechnology

28/03/2023 14:31

* PDS Biotechnology Corp  PDSB.OQ  reported a quarterly
adjusted
loss of 67 cents​​ per share for the quarter ended in December.
The mean expectation of seven analysts for the quarter was for a
loss of 29 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * PDS Biotechnology Corp's reported EPS for the quarter was
a loss
of 67 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * PDS Biotechnology Corp shares had fallen by 57.0% this
quarter.
    * The company reported a quarterly loss of $19.14 million.
    * Wall Street's median 12-month price target for PDS
Biotechnology
Corp is $19.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 28 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.29          -0.67          Missed
 Sep. 30 2022      -0.28          -0.26          Beat
 Jun. 30 2022      -0.28          -0.20          Beat
 Mar. 31 2022      -0.22          -0.32          Missed